Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study.

Thomas PayneMatilde SassaniEllen E BuckleySarah MollAdriana AntonMatthew ApplebySeema MaruRosie TaylorAlisdair McNeillN HoggardClaudia MazzaIain D WilkinsonThomas JenkinsThomas FoltynieOliver Bandmann

Published in: BMJ open (2020)

NCT03840005.

Keyphrases

double blind
placebo controlled
clinical trial
study protocol
open label
phase ii
combination therapy